Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Encompass Health Corporation    EHC

ENCOMPASS HEALTH CORPORATION

(EHC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization1 4 8586 1046 8306 094--
Entreprise Value (EV)1 7 3818 5499 7989 2639 4809 062
P/E ratio 18,4x21,1x19,2x19,1x15,8x13,7x
Yield 1,98%1,69%1,59%1,84%1,88%1,97%
Capitalization / Revenue 1,22x1,43x1,48x1,30x1,18x1,11x
EV / Revenue 1,86x2,00x2,13x1,97x1,83x1,64x
EV / EBITDA 8,97x9,49x10,2x10,5x9,23x8,17x
Price to Book 4,11x4,54x5,02x3,40x2,90x2,41x
Nbr of stocks (in thousands) 98 31198 92898 60099 405--
Reference price (USD) 49,461,769,361,361,361,3
Last update 02/26/201802/07/201902/06/202006/03/202006/03/202005/01/2020
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales1 3 9714 2774 6054 6995 1675 513
EBITDA1 8239019658831 0271 110
Operating profit (EBIT)1 639630693657774849
Operating Margin 16,1%14,7%15,0%14,0%15,0%15,4%
Pre-Tax Profit (EBT)1 496493562466600679
Net income1 256292359314385449
Net margin 6,45%6,83%7,79%6,68%7,46%8,15%
EPS2 2,692,933,613,223,884,48
Dividend per Share2 0,981,041,101,131,151,21
Last update 02/26/201802/07/201902/06/202006/03/202006/03/202006/03/2020
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt1 2 5232 4452 9683 1703 3862 968
Net Cash position1 ------
Leverage (Debt / EBITDA) 3,07x2,71x3,08x3,59x3,30x2,68x
Free Cash Flow1 468508517272417390
ROE (Net Profit / Equities) 26,7%28,9%27,3%22,4%23,3%21,9%
Shareholders' equity1 9591 0121 3141 4001 6572 051
ROA (Net Profit / Asset) 5,35%-6,37%5,92%7,85%7,98%
Assets1 4 788-5 6285 2964 9075 627
Book Value Per Share2 12,013,613,818,021,225,5
Cash Flow per Share2 6,627,646,395,397,789,32
Capex1 226255372316408456
Capex / Sales 5,69%5,95%8,09%6,72%7,89%8,27%
Last update 02/26/201802/07/201902/06/202007/07/202007/07/202006/24/2020
1 USD in Million
2 USD
Estimates
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (USD)
6 093 533 365
Net sales (USD)
4 605 000 000
Number of employees
35 690
Sales / Employee (USD)
129 028
Free-Float
85,8%
Free-Float capitalization (USD)
5 229 729 059
Avg. Exchange 20 sessions (USD)
54 003 660
Average Daily Capital Traded
0,89%
EPS & Dividend